Ontology highlight
ABSTRACT:
SUBMITTER: Hinnen D
PROVIDER: S-EPMC5556578 | biostudies-literature | 2017 Aug
REPOSITORIES: biostudies-literature
Diabetes spectrum : a publication of the American Diabetes Association 20170801 3
The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects. The physiological response to oral ingestion of nutrients, involving the incretin system, is reduced in some patients with type 2 diabetes but may be augmented by administration of GLP-1 receptor agonists. The GLP-1 receptor agonists currently approved in the United States for the treatment of type ...[more]